F410
FOXO4-DRI
Supplied as a lyophilized powder in a research pack of ten vials, each containing 10mg.
Highlights
- 100mg total material
- Ten-vial pack format
- Certificate of analysis
Typical research applications
- Method development reference
- Protocol optimization studies
Lot and handling notes
The product is a lyophilized powder format, presented in individual glass vials. It is designated for laboratory research purposes.
Each order unit contains ten vials with 10mg per vial, totaling 100mg. A certificate of analysis is provided for the batch.
Specifications
| Product | |
|---|---|
| Abbreviation | F410 |
| Form | Lyophilized material |
| Pack sizes | 10mg*10vials |
| Analysis | |
| Measured content | 10mg: 11.81mg |
| Documentation | |
| Lot record | Certificate of analysis listed for this product |
Related items
RT
Retatrutide
TR
Tirzepatide
Cu50
GHK-Cu